Study 60 Of Lung Cancer Patients Saw Covid19related Treatment Delays | Latest News RSS Feed

Study 60 Of Lung Cancer Patients Saw Covid19related Treatment Delays - Latest News

Immunotherapy drug boosts survival for lung cancer patients

RELATED Study: 60% of lung cancer patients saw COVID-19-related treatment delays Median progression-free survival -- the time from treatment to the disease beginning to worsen -- was eight months ... read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

Why are cancer patients still being left in limbo? It's become the untold scandal of Covid

Meanwhile, a recent study ... delays in diagnosis could lead to between 1,235 to 1,372 extra lung cancer deaths in England. Patients already diagnosed with lung cancer have suffered delays in ... read more

Lockdown's lethal toll on NHS and vulnerable patients laid bare

At least 25,000 more people have died at home during the pandemic in England and Wales because they were unable to - or chose not to - go to hospital, a surge of 43.8 per cent on normal levels. read more

Looking for other news?

COVID-19 Outbreak at Psychiatric Hospital Spurs Lawsuit

About 115 patients and 150 ... Hart had lung cancer last year and is at high risk of serious illness if he contracts the virus. According to Hadreas, Hart has been deemed “low-risk” and doesn’t need ... read more

ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front

Roche is already seeking FDA approval of entrectinib for lung ... cancer who have failed two treatments. The data, from a study called TRITON2, showed 44 percent of patients responded to treatment. read more

Amgen Inc. (AMGN) CEO Robert Bradway on Q3 2020 Results - Earnings Call Transcript

AMGN) Q3 2020 Earnings Conference Call October 28, 2020 05:00 PM ET Company Participants Arvind Sood - Vice President of Investor Relations Robert Bradway - Chairman and Chief Executive Officer David ... read more

Seagen's (SGEN) CEO Clay Siegall on Q3 2020 Results - Earnings Call Transcript

At Seagen, we remain committed to delivering innovative cancer medicines to patients ... treatment. And so it was or five or six cycles, I should say. That's what we have approved. Now, if you saw ... read more

Cancer sufferer dead at 31 after her chemo was 'paused' due to Covid

Her cancer spread and she died on June 13. Miss Smith is just one of thousands of cancer patients abandoned by the NHS when the coronavirus crisis hit. Hospitals desperate to clear beds for Covid ... read more

Coronavirus live news: intensive care patients in France hit highest number since May; global cases pass 40m

She went straight to surgery, which confirmed she had a slow-growing lung cancer. Helen’s story ... leading to delays in diagnosis and treatment. Spain’s cumulative tally of coronavirus ... read more

The Article That Could Help Save Black Women's Lives

In a 2016 study, researchers videotaped interactions between nonblack oncologists and their black patients at cancer hospitals in Detroit ... (Meanwhile, any delay in seeking treatment, says Speight, ... read more

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Eligible patients had a Karnofsky performance-status score of at least 60 percent, no prior treatment ... of the study. Only the data and safety monitoring committee saw the results of the interim ... read more

PARP Inhibitors Demonstrate the Value of Targeted Treatments in Prostate Cancer

Primed to knock out cells vulnerable due to DNA-repair problems, PARP inhibitors are ushering in a targeted-drug era in prostate cancer treatment. Darryl Elzy, 60 ... the study, including those with ... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us